InvestorsHub Logo

TJG

Followers 604
Posts 27489
Boards Moderated 2
Alias Born 06/20/2007

TJG

Re: None

Thursday, 01/25/2024 7:26:13 PM

Thursday, January 25, 2024 7:26:13 PM

Post# of 6601
Up to .1299 in after hours.... buyers are coming in.... Just remember everyone, not a single Bio Tech stock that has products in trial is going to show you any type of balance any different then the ones posted here... also do your own DD, I would look up the Outstanding share count for Jaguar .. when and IF, always add the if, when speaking about the future of a stock, they get a positive results from the Phase III trial, they will have more cash then they know what to do with. Here are last years financials for the company which lists their OS.

For the last Q reported there were 50,775,000 share outstanding

For the Q filed on Aug 14 there as 19,117,000 shares outstanding

For the Q filed on May 15 there were 19,097,000 shares outstanding

For the K filed as of March 24 of 2023 there were 13,862,000 share outstanding.

So as they moved through the year of 2023 with a Phase 2 and a Phase 3 trial costs as well as other normal business expenses the company had a total of 37,000,000 shares diluted. Right in line with any bio tech I have been in over the past 10 or 15 years... So for me its business as normal while they await approval of a drug that will will product(s) that will be worth hundreds of millions of dollars.

As of 7:30 pm After Hours PPS is .1323

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News